Sivik Global Healthcare LLC In its 13F for Q1 2026 (holdings as of March 31, 2026, filed April 15, 2026), Sivik Global Healthcare LLC reported 34 stock positions worth $131.7 million . Its top holding was SS SPDR S&P Biotech ETF (XBI) at 14.5% of the portfolio, followed by Cardinal Health (CAH, 3.9% ) and Call- BSX 100 @ 75 Exp 04/17/2026 (3.8% ). Compared with Q4 2025, it opened 6 new positions, sold out of 13, added to 2 and reduced 24. The biggest buy was a new position in Call- BSX 100 @ 75 Exp 04/17/2026 and the biggest sale an exit from HCA Healthcare (HCA).
Location GREENWICH, CT
CIK 0001596452
Portfolio Value $131.7M (Q1 2026) Holdings 34 stocks · $131.7M Holdings quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock % Of Portfolio ▼ Shares Held Total Value Change vs Q4 2025 XBI SS SPDR S&P Biotech ETF 150,000 $19.2M Reduce -33.3% CAH Cardinal Health Inc. 24,000 $5.1M Reduce -26.1% CALL- BSX 100 @ 75 EXP 04/17/2026 800 $5.0M New JNJ Johnson & Johnson 20,000 $4.9M New MRK Merck & Co. Inc. 40,000 $4.8M Add +33.3% COR Cencora Inc. 15,000 $4.7M Reduce -16.7% LLY Eli Lilly & Co. 5,000 $4.6M Reduce -28.6% WAT Waters Corp. 15,000 $4.5M New VRTX Vertex Pharmaceuticals Inc. 10,000 $4.5M Reduce -27.4% ISRG Intuitive Surgical Inc. 9,000 $4.1M Reduce -10.0% AZN Astrazeneca PLC 20,000 $3.9M No change TMO Thermo Fisher Scientific Inc. 8,000 $3.9M Reduce -33.3% BSX Boston Scientific Corp. 62,000 $3.9M Reduce -11.4% DHR Danaher Corp. 20,000 $3.8M Reduce -13.0% THC Tenet Healthcare Corp. 20,000 $3.8M Reduce -46.7% GILD Gilead Sciences Inc. 25,000 $3.5M No change HUM Humana Inc. 20,000 $3.5M Add +33.3% MTD Mettler-Toledo International 2,750 $3.5M Reduce -8.3% MCK McKesson Corp. 4,000 $3.5M Reduce -55.6% A Agilent Technologies Inc. 30,000 $3.4M Reduce -14.3% SYK Stryker Corp. 10,000 $3.3M Reduce -23.1% ABBV Abbvie Inc. 15,000 $3.3M Reduce -25.0% UHS Universal Health Services-B 17,500 $3.1M Reduce -37.5% REGN Regeneron Pharmaceuticals 4,000 $3.1M New BIO Bio-Rad Laboratories-A 10,000 $2.8M Reduce -16.7% BIIB Biogen Inc. 15,000 $2.8M Reduce -25.0% UNH Unitedhealth Group Inc. 10,000 $2.7M Reduce -16.7% GMED Globus Medical Inc. Class A 30,000 $2.6M Reduce -25.0% ABT Abbott Laboratories 25,000 $2.6M Reduce -37.5% EW Edwards Lifesciences Corp. 20,000 $1.6M Reduce -42.9% SNN Smith & Nephew PLC -Spon ADR 50,000 $1.6M Reduce -60.0% ELV Elevance Health Inc. 5,000 $1.5M New EHC Encompass Health Corp. 15,000 $1.5M Reduce -70.0% CVS CVS Health Corp. 20,000 $1.4M New
Portfolio Sells Q4 2025 → Q1 2026 Portfolio Sells quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q4 2025 % Of Portfolio Change To Portfolio ▲ HCA HCA Healthcare Inc. Sold out 0.00% −3.42 MDT Medtronic PLC Sold out 0.00% −2.11 RGEN Repligen Corp. Sold out 0.00% −2.00 BDX Becton Dickinson and Co. Sold out 0.00% −1.89 NVO Novo-Nordisk A/S-Spons ADR Sold out 0.00% −1.86 SGRY Surgery Partners Inc. Sold out 0.00% −1.51 BRKR Bruker Corp. Sold out 0.00% −1.50 EHC Encompass Health Corp. Reduce -70.0% 1.10% −1.49 GEHC GE Healthcare Technology Sold out 0.00% −1.40 SEM Select Medical Holdings Corp. Sold out 0.00% −1.38 TECH Bio-Techne Corp. Sold out 0.00% −1.29 MCK McKesson Corp. Reduce -55.6% 2.63% −0.98 SNN Smith & Nephew PLC -Spon ADR Reduce -60.0% 1.21% −0.80 THC Tenet Healthcare Corp. Reduce -46.7% 2.87% −0.77 CGON CG Oncology Inc. Sold out 0.00% −0.71 ARGX Argenx SE - ADR Sold out 0.00% −0.62 UHS Universal Health Services-B Reduce -37.5% 2.38% −0.60 ALNY Alnylam Pharmaceuticals Inc. Sold out 0.00% −0.58 ABT Abbott Laboratories Reduce -37.5% 1.95% −0.50 TMO Thermo Fisher Scientific Inc. Reduce -33.3% 2.99% −0.41 BSX Boston Scientific Corp. Reduce -11.4% 2.95% −0.30 EW Edwards Lifesciences Corp. Reduce -42.9% 1.22% −0.24 LLY Eli Lilly & Co. Reduce -28.6% 3.49% −0.18 UNH Unitedhealth Group Inc. Reduce -16.7% 2.05% +0.12 ABBV Abbvie Inc. Reduce -25.0% 2.48% +0.25 GMED Globus Medical Inc. Class A Reduce -25.0% 1.96% +0.26 SYK Stryker Corp. Reduce -23.1% 2.50% +0.26 A Agilent Technologies Inc. Reduce -14.3% 2.60% +0.27 DHR Danaher Corp. Reduce -13.0% 2.88% +0.31 BIO Bio-Rad Laboratories-A Reduce -16.7% 2.12% +0.34 VRTX Vertex Pharmaceuticals Inc. Reduce -27.4% 3.39% +0.34 BIIB Biogen Inc. Reduce -25.0% 2.09% +0.37 ISRG Intuitive Surgical Inc. Reduce -10.0% 3.15% +0.39 CAH Cardinal Health Inc. Reduce -26.1% 3.85% +0.59 MTD Mettler-Toledo International Reduce -8.3% 2.63% +0.59 COR Cencora Inc. Reduce -16.7% 3.58% +0.61 XBI SS SPDR S&P Biotech ETF Reduce -33.3% 14.55% +1.16
Portfolio Buys Q4 2025 → Q1 2026 Portfolio Buys quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q4 2025 % Of Portfolio Change To Portfolio ▼ CALL- BSX 100 @ 75 EXP 04/17/2026 New 3.81% +3.81 JNJ Johnson & Johnson New 3.71% +3.71 WAT Waters Corp. New 3.39% +3.39 REGN Regeneron Pharmaceuticals New 2.35% +2.35 MRK Merck & Co. Inc. Add +33.3% 3.65% +2.11 ELV Elevance Health Inc. New 1.11% +1.11 CVS CVS Health Corp. New 1.09% +1.09 HUM Humana Inc. Add +33.3% 2.63% +0.76
Options Activity Q4 2025 → Q1 2026 Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.
All Filings Quarter Positions 13F Reported Value Top Holdings Q2 2026 34 $131.7M XBI, CAH, CALL- BSX 100 @ 75 EXP 04/17/2026, JNJ, MRK Q1 2026 34 $131.7M XBI, CAH, CALL- BSX 100 @ 75 EXP 04/17/2026, JNJ, MRK Q4 2025 41 $204.8M XBI, LLY, THC, MCK, HCA Q3 2025 35 $190.5M XBI, LLY, HCA, THC, DHR Q2 2025 38 $223.6M XBI, THC, HCA, MCK, UHS Q1 2025 29 $182.9M XBI, BSX, THC, HCA, LLY Q4 2024 36 $180.8M XBI, LLY, BSX, MCK, SYK Q3 2024 33 $234.6M XBI, LLY, THC, NVO, UHS Q2 2024 37 $223.9M LLY, NVO, MCK, THC, BSX Q1 2024 46 $275.1M XBI, LLY, NVO, BSX, TMO